Comparing high levels of PTEN mRNA (Quartile 4, Q4) to lower (Q1 + 2 + 3) levels did not distinguish overall survival in ovarian cancer patients (Fig 1F). This evidence concerns the gene PTEN and ovarian carcinoma.